CORD-19:85d7f47649ef43ff11b8d5196c98e4fdacd0f905 / 12697-12906 JSONTXT

{"project":"CORD-PICO","denotations":[{"id":"p1_all26","span":{"begin":82,"end":106},"obj":"Intervention"},{"id":"p1_all27","span":{"begin":120,"end":149},"obj":"Outcome"}],"text":"Importantly, treatment with catalytically active, but not enzymatically inactive, recombinant ACE2 protein improved the symptoms of acute lung injury in wild-type mice, as well as in ace2 knockout mice [26 ] ."}

{"project":"CORD-19-Sentences","denotations":[{"id":"TextSentencer_T79","span":{"begin":0,"end":209},"obj":"Sentence"},{"id":"TextSentencer_T79","span":{"begin":0,"end":209},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Importantly, treatment with catalytically active, but not enzymatically inactive, recombinant ACE2 protein improved the symptoms of acute lung injury in wild-type mice, as well as in ace2 knockout mice [26 ] ."}

{"project":"CORD-19_Custom_license_subset","denotations":[{"id":"T79","span":{"begin":0,"end":209},"obj":"Sentence"}],"text":"Importantly, treatment with catalytically active, but not enzymatically inactive, recombinant ACE2 protein improved the symptoms of acute lung injury in wild-type mice, as well as in ace2 knockout mice [26 ] ."}

{"project":"CORD-19-PD-UBERON","denotations":[{"id":"T76","span":{"begin":138,"end":142},"obj":"Body_part"}],"attributes":[{"id":"A76","pred":"uberon_id","subj":"T76","obj":"http://purl.obolibrary.org/obo/UBERON_0002048"}],"text":"Importantly, treatment with catalytically active, but not enzymatically inactive, recombinant ACE2 protein improved the symptoms of acute lung injury in wild-type mice, as well as in ace2 knockout mice [26 ] ."}

{"project":"CORD-19-PD-MONDO","denotations":[{"id":"T133","span":{"begin":132,"end":149},"obj":"Disease"},{"id":"T135","span":{"begin":143,"end":149},"obj":"Disease"},{"id":"T94557","span":{"begin":132,"end":149},"obj":"Disease"},{"id":"T75671","span":{"begin":143,"end":149},"obj":"Disease"}],"attributes":[{"id":"A133","pred":"mondo_id","subj":"T133","obj":"http://purl.obolibrary.org/obo/MONDO_0006502"},{"id":"A134","pred":"mondo_id","subj":"T133","obj":"http://purl.obolibrary.org/obo/MONDO_0015796"},{"id":"A135","pred":"mondo_id","subj":"T135","obj":"http://purl.obolibrary.org/obo/MONDO_0021178"},{"id":"A5095","pred":"mondo_id","subj":"T94557","obj":"http://purl.obolibrary.org/obo/MONDO_0006502"},{"id":"A46039","pred":"mondo_id","subj":"T94557","obj":"http://purl.obolibrary.org/obo/MONDO_0015796"},{"id":"A26838","pred":"mondo_id","subj":"T75671","obj":"http://purl.obolibrary.org/obo/MONDO_0021178"}],"text":"Importantly, treatment with catalytically active, but not enzymatically inactive, recombinant ACE2 protein improved the symptoms of acute lung injury in wild-type mice, as well as in ace2 knockout mice [26 ] ."}